309 related articles for article (PubMed ID: 32914148)
41. The Role of Sphingolipids in Allergic Disorders.
Díaz-Perales A; Escribese MM; Garrido-Arandia M; Obeso D; Izquierdo-Alvarez E; Tome-Amat J; Barber D
Front Allergy; 2021; 2():675557. PubMed ID: 35386967
[TBL] [Abstract][Full Text] [Related]
42. Role of Bioactive Sphingolipids in Inflammation and Eye Diseases.
Mondal K; Mandal N
Adv Exp Med Biol; 2019; 1161():149-167. PubMed ID: 31562629
[TBL] [Abstract][Full Text] [Related]
43. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
Ueda N
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
[TBL] [Abstract][Full Text] [Related]
44. Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids.
Kihara A
Biochim Biophys Acta; 2014 May; 1841(5):766-72. PubMed ID: 23994042
[TBL] [Abstract][Full Text] [Related]
45. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction.
Liu S; Yuan Y; Xue Y; Xing C; Zhang B
Front Cell Dev Biol; 2022; 10():832887. PubMed ID: 35321238
[TBL] [Abstract][Full Text] [Related]
46. Bioactive sphingolipids in response to chemotherapy: a scope on leukemias.
Ekiz HA; Baran Y
Anticancer Agents Med Chem; 2011 May; 11(4):385-97. PubMed ID: 21453240
[TBL] [Abstract][Full Text] [Related]
47. The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.
Kravets I; Mallipattu SK
J Endocr Soc; 2020 Apr; 4(4):bvaa029. PubMed ID: 32232184
[TBL] [Abstract][Full Text] [Related]
48. Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage.
Khan SA; Goliwas KF; Deshane JS
Front Physiol; 2021; 12():760638. PubMed ID: 34690821
[TBL] [Abstract][Full Text] [Related]
49. New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism.
Kleuser B; Schumacher F; Gulbins E
Handb Exp Pharmacol; 2024; 284():289-312. PubMed ID: 37922034
[TBL] [Abstract][Full Text] [Related]
50. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
51. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
[TBL] [Abstract][Full Text] [Related]
52. Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment.
Janneh AH; Ogretmen B
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565311
[TBL] [Abstract][Full Text] [Related]
53. The role of sphingolipids in respiratory disease.
Yang Y; Uhlig S
Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer.
Espinoza KS; Snider AJ
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398179
[TBL] [Abstract][Full Text] [Related]
55. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
56. Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.
Kawabori M; Kacimi R; Karliner JS; Yenari MA
World J Cardiol; 2013 Apr; 5(4):75-86. PubMed ID: 23675553
[TBL] [Abstract][Full Text] [Related]
57. Updates on sphingolipids: Spotlight on retinopathy.
Shiwani HA; Elfaki MY; Memon D; Ali S; Aziz A; Egom EE
Biomed Pharmacother; 2021 Nov; 143():112197. PubMed ID: 34560541
[TBL] [Abstract][Full Text] [Related]
58. Sphingolipids Signaling in Lamellipodia Formation and Enhancement of Endothelial Barrier Function.
Fu P; Shaaya M; Harijith A; Jacobson JR; Karginov A; Natarajan V
Curr Top Membr; 2018; 82():1-31. PubMed ID: 30360778
[TBL] [Abstract][Full Text] [Related]
59. Sphingolipids in cancer.
Furuya H; Shimizu Y; Kawamori T
Cancer Metastasis Rev; 2011 Dec; 30(3-4):567-76. PubMed ID: 22005951
[TBL] [Abstract][Full Text] [Related]
60. Re-configuration of sphingolipid metabolism by oncogenic transformation.
Don AS; Lim XY; Couttas TA
Biomolecules; 2014 Mar; 4(1):315-53. PubMed ID: 24970218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
